Drug firms 'bury' poor trial results - The Independent on Sunday 20th January 2008

Drug companies are placing depressed patients at risk by not publishing negative results from clinical trials and distorting the evidence doctors use to decide which drugs to prescribe. New research published in The New England Journal of Medicine found nearly a third of the 74 industry-sponsored studies of antidepressants they examined were not published, most of which showed negative outcomes for the drug involved. Not only were positive results 12 times more likely to be published, but negative results were often written so as to convey a favourable outcome.

Link to Article